Literature DB >> 18469093

Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.

Dan M Waid1, Gisela M Vaitaitis, Nathan D Pennock, David H Wagner.   

Abstract

Although regulatory T cells (Tregs) are well described, identifying autoaggressive effector T cells has proven more difficult. However, we identified CD4loCD40+ (Th40) cells as being necessary and sufficient for diabetes in the NOD mouse model. Importantly, these cells are present in pancreata of prediabetic and diabetic NOD mice, and Th40 cells but not CD4+CD40(-) T cells transfer progressive insulitis and diabetes to NOD.scid recipients. Nonobese-resistant (NOR) mice have the identical T cell developmental background as NOD mice, yet they are diabetes-resistant. The seminal issue is how NOR mice remain tolerant to diabetogenic self-antigens. We show here that autoaggressive T cells develop in NOR mice and are confined to the Th40 subset. However, NOR mice maintain Treg numbers equivalent to their Th40 numbers. NOD mice have statistically equal numbers of CD4+CD25+forkhead box P3+intrinsic Tregs compared with NOR or nonautoimmune BALB/c mice, and NOD Tregs are equally as suppressive as NOR Tregs. A critical difference is that NOD mice develop expanded numbers of Th40 cells. We suggest that a determinant factor for autoimmunity includes the Th40:Treg ratio. Mechanistically, NOD Th40 cells have low susceptibility to Fas-induced cell death and unlike cells from NOR and BALB/c mice, have predominantly low Fas expression. CD40 engagement of Th40 cells induces Fas expression but further confers resistance to Fas-mediated cell death in NOD mice. A second fundamental difference is that NOD Th40 cells undergo much more rapid homeostatic expansion than Th40 cells from NOR mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18469093      PMCID: PMC2493071          DOI: 10.1189/jlb.1207857

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  57 in total

Review 1.  Hypothesis: A recurrent, moderate activation fosters systemic autoimmunity--the apoptotic roles of TCR, IL-2 and Fas ligand.

Authors:  K Matsui; S Jodo; S Xiao; S T Ju
Journal:  J Biomed Sci       Date:  1999 Sep-Oct       Impact factor: 8.410

Review 2.  Re-shaping the T cell repertoire: TCR editing and TCR revision for good and for bad.

Authors:  David H Wagner
Journal:  Clin Immunol       Date:  2006-09-20       Impact factor: 3.969

3.  Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.

Authors:  Pascale Alard; Jean N Manirarora; Sarah A Parnell; Jason L Hudkins; Sherry L Clark; Michele M Kosiewicz
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

4.  Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout.

Authors:  Jean M Jasinski; Liping Yu; Maki Nakayama; Marcella M Li; Myra A Lipes; George S Eisenbarth; Edwin Liu
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

5.  GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.

Authors:  Viveka Oling; Jane Marttila; Jorma Ilonen; William W Kwok; Gerald Nepom; Mikael Knip; Olli Simell; Helena Reijonen
Journal:  J Autoimmun       Date:  2005-11-02       Impact factor: 7.094

6.  Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitus.

Authors:  Dan M Waid; Gisela M Vaitaitis; David H Wagner
Journal:  Eur J Immunol       Date:  2004-05       Impact factor: 5.532

7.  Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells.

Authors:  Michael Stassen; Sabine Fondel; Tobias Bopp; Christoph Richter; Christian Müller; Jan Kubach; Christian Becker; Jürgen Knop; Alexander H Enk; Steffen Schmitt; Edgar Schmitt; Helmut Jonuleit
Journal:  Eur J Immunol       Date:  2004-05       Impact factor: 5.532

8.  Enhanced levels of CD154 (CD40 ligand) on platelets in patients with chronic heart failure.

Authors:  Christian Stumpf; Christoph Lehner; Saeed Eskafi; Dorette Raaz; Atilla Yilmaz; Susanne Ropers; Alexander Schmeisser; Joseph Ludwig; Werner G Daniel; Christoph D Garlichs
Journal:  Eur J Heart Fail       Date:  2003-10       Impact factor: 15.534

9.  T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading.

Authors:  Patrick A Ott; Marcus T Dittrich; Bernhard A Herzog; Robert Guerkov; Peter A Gottlieb; Amy L Putnam; Ivana Durinovic-Bello; Bernhard O Boehm; Magdalena Tary-Lehmann; Paul V Lehmann
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

10.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  23 in total

Review 1.  The biology of FoxP3: a key player in immune suppression during infections, autoimmune diseases and cancer.

Authors:  Frances Mercer; Derya Unutmaz
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

2.  CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity.

Authors:  Gisela M Vaitaitis; David H Wagner
Journal:  Mol Immunol       Date:  2010-06-19       Impact factor: 4.407

3.  The co-evolution of our understanding of CD40 and inflammation.

Authors:  D H Wagner
Journal:  Diabetologia       Date:  2009-04-10       Impact factor: 10.122

Review 4.  Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).

Authors:  D H Wagner
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

5.  Age-dependent divergent effects of OX40L treatment on the development of diabetes in NOD mice.

Authors:  Christine S Haddad; Palash Bhattacharya; Khaled Alharshawi; Alejandra Marinelarena; Prabhakaran Kumar; Osama El-Sayed; Hatem A Elshabrawy; Alan L Epstein; Bellur S Prabhakar
Journal:  Autoimmunity       Date:  2016-05-31       Impact factor: 2.815

Review 6.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

7.  Elimination of T cell reactivity to pancreatic β cells and partial preservation of β cell activity by peptide blockade of LFA-1:ICAM-1 interaction in the NOD mouse model.

Authors:  Abby L Dotson; Lesya Novikova; Lisa Stehno-Bittel; Stephen H Benedict
Journal:  Clin Immunol       Date:  2013-05-09       Impact factor: 3.969

8.  An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.

Authors:  Gisela M Vaitaitis; Jessica R Carter; Dan M Waid; Michael H Olmstead; David H Wagner
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

9.  Pro-inflammatory T-lymphocytes rapidly infiltrate into the brain and contribute to neuronal injury following cardiac arrest and cardiopulmonary resuscitation.

Authors:  Guiying Deng; Jessica Carter; Richard J Traystman; David H Wagner; Paco S Herson
Journal:  J Neuroimmunol       Date:  2014-07-22       Impact factor: 3.478

10.  Helminth infection can reduce insulitis and type 1 diabetes through CD25- and IL-10-independent mechanisms.

Authors:  Qian Liu; Krishnan Sundar; Pankaj K Mishra; Gity Mousavi; Zhugong Liu; Andrew Gaydo; Farhang Alem; David Lagunoff; David Bleich; William C Gause
Journal:  Infect Immun       Date:  2009-09-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.